Clinical Trials (PDQ®) - National Cancer Institute

Page Options

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp online chat

	NCI Highlights


	Maintenance Rituximab for Follicular Lymphoma Azacitidine Improves Survival in MDS Second Stem Cell Transplant Not Helpful in Myeloma

Life After Cancer Treatment Study

Basic Trial Information
Trial Description
     Summary
     Further Trial Information
     Eligibility Criteria
Trial Contact Information

Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs
No phase specified Supportive care Active 18 and over Other 1 R21-CA107428-01A2
NCT00473941

Trial Description

Summary

The purpose of the study is to find new ways to improve the quality of life of people who have been treated for colon or rectal cancer.

Further Study Information

Individuals who take part in the study can expect:

Two Interviews:

To be interviewed by our research staff over the phone. The interviews will include questions about your current quality of life and health.

Brief Writing in a Journal:

To write for 15 minutes twice a week for two weeks about aspects of your life.

Eligibility Criteria

Inclusion Criteria:

Treated for stage I, II or III colon or rectal cancer in the past 5 years

Completed surgical treatment

Must be able to read and write in English

Exclusion Criteria:

History of other cancers, with the exception of non-melanoma skin cancer

Trial Contact Information

Trial Lead Organizations/Sponsors

Fox Chase Cancer Center - Philadelphia

Stephen Lepore, Ph.D.

Principal Investigator

Tracey A Revenson, Ph.D

Principal Investigator

Deborah L Knorr, MPH		Ph: 1-888-853-1697
		Email: lifeaftercancer@temple.edu

Trial Sites

U.S.A.

Pennsylvania

Philadelphia

Temple Cancer Center at Temple University Hospital

Deborah L Knorr, MPH Ph: 888-853-1679

Email: lifeaftercancer@temple.edu

See All Trial Sites

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00473941
Information obtained from ClinicalTrials.gov on March 18, 2009

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.